DYMISTA Drug Profile, 2024: DYMISTA (azelastine hydrochloride; fluticasone propionate) drug patents, FDA exclusivity, litigation, sales revenues

by DrugPatentWatch

DYMISTA Drug Profile, 2024

This report focuses on DYMISTA and covers the following critical aspects of this drug:

United States patentsExpired United States patentsFDA Paragraph IV patent challengesDistrict Court patent litigationPatent Trial and Appeal Board (PTAB) patent casesEuropean supplementary protection certificates (SPCs)Clinical trialsDrug pricesAnnual sales revenuesFinished product suppliersRaw active pharmaceutical ingredient (API)...

• Format: Paperback
• Language: English
• ISBN: B0CRZ4N287
• ISBN13: 9798875589034
• Release Date: January 2024
• Publisher: Independently Published
• Length: 50 Pages
• Weight: 0.31 lbs.
• Dimensions: 0.1" x 8.5" x 11.0"